Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Central-boost Ablative Radiation Therapy for Large Tumors or Tumors Adjacent to Organs at Risk

NCT06427460 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT06427460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06427460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Central-boost Ablative Radiation Therapy for Large Tumors or Tumors Adjacent to Organs at Risk
Lead sponsor
Changhai Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
May 12, 2024
Completion date
December 31, 2026
Enrollment
67 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer